← All trials
NCT07020949
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 13, 2024
- Primary completion
- Nov 27, 2024
- Completion date
- Nov 27, 2024
- First posted
- Jun 13, 2025
- Last posted
- Jun 13, 2025
- Enrollment
- 49
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Tonghua Dongbao Pharmaceutical Co.,LtdLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.